It Could be a Big December for Biotech ETFs
December 04, 2014 at 08:20 AM EST
Already occupying the top five spots among non-leveraged sector exchange traded funds this year, biotech ETFs could end 2014 with a bang if a spate of expected decisions by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) bring positive news. Several important new...